<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Surgery and Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Surgery and Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Хирургия и онкология</trans-title></trans-title-group></journal-title-group><issn publication-format="electronic">2949-5857</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">125</article-id><article-id pub-id-type="doi">10.17650/2220-3478-2015-1-49-53</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">CHARACTERISTICS OF CLINICAL COURSE OF METASTATIC AND PRIMARY OVARIAN TUMORS IN COLON CANCER</article-title><trans-title-group xml:lang="ru"><trans-title>ОСОБЕННОСТИ КЛИНИЧЕСКОГО ТЕЧЕНИЯ МЕТАСТАТИЧЕСКИХ И ПЕРВИЧНЫХ ОПУХОЛЕЙ ЯИЧНИКОВ ПРИ РАКЕ ТОЛСТОЙ КИШКИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dzhanyan</surname><given-names>I. A.</given-names></name><name xml:lang="ru"><surname>Джанян</surname><given-names>И. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>N.N. Blokhin Russian Cancer Research Center; 24 Kashirskoye Shosse, Moscow, 115478, Russia</p></bio><bio xml:lang="ru"><p> <italic>ФГБНУ «РОНЦ им. Н.Н. Блохина»; Россия, 115478, Москва, Каширское шоссе, 24</italic></p><p> </p></bio><email>ikislichko@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Komarov</surname><given-names>I. G.</given-names></name><name xml:lang="ru"><surname>Комаров</surname><given-names>И. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>N.N. Blokhin Russian Cancer Research Center; 24 Kashirskoye Shosse, Moscow, 115478, Russia</p></bio><bio xml:lang="ru"><p> <italic>ФГБНУ «РОНЦ им. Н.Н. Блохина»; Россия, 115478, Москва, Каширское шоссе, 24</italic></p><p> </p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Payanidi</surname><given-names>Y. G.</given-names></name><name xml:lang="ru"><surname>Паяниди</surname><given-names>Ю. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>N.N. Blokhin Russian Cancer Research Center; 24 Kashirskoye Shosse, Moscow, 115478, Russia</p></bio><bio xml:lang="ru"><p> <italic>ФГБНУ «РОНЦ им. Н.Н. Блохина»; Россия, 115478, Москва, Каширское шоссе, 24</italic></p><p> </p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin Russian Cancer Research Center</institution></aff><aff><institution xml:lang="ru">ФГБНУ «РОНЦ им. Н.Н. Блохина»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-05-26" publication-format="electronic"><day>26</day><month>05</month><year>2015</year></pub-date><volume>5</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>49</fpage><lpage>53</lpage><history><date date-type="received" iso-8601-date="2015-05-26"><day>26</day><month>05</month><year>2015</year></date><date date-type="accepted" iso-8601-date="2015-05-26"><day>26</day><month>05</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Dzhanyan I.A., Komarov I.G., Payanidi Y.G.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Джанян И.А., Комаров И.Г., Паяниди Ю.Г.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Dzhanyan I.A., Komarov I.G., Payanidi Y.G.</copyright-holder><copyright-holder xml:lang="ru">Джанян И.А., Комаров И.Г., Паяниди Ю.Г.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://onco-surgery.info/jour/article/view/125">https://onco-surgery.info/jour/article/view/125</self-uri><abstract xml:lang="en"><p><italic>Th</italic><italic>e aim of this study was to investigate clinical pecuiliarities of ovarian tumors in colon cancer patients and determination of complex diagnostic methods.</italic></p><p><bold><italic>Subjec</italic></bold><bold><italic>t and methods. </italic></bold><italic>Russia</italic><italic>n N.N.  Blokhin Cancer Research Center archives were used for retrospective study, patients, who underwent treatment during 1989–2013  were included. Colon cancer patients with ovarian metastases and with synchronous or metachronous tumors were included.</italic></p><p><bold><italic>Results</italic></bold><bold><italic>. </italic></bold><italic>14</italic><italic>1 patients were included: 91 patients had colon cancer with ovarian metastases (group 1) and 50 patients had synchronous or metachronous ovarian tumours (group 2). Ovarian tumors were diagnosed during the 1 year in 74 (81.3 %) patients in group 1 and in 23 (46 %) in group 2. Patients in group 2 less frequently had children (9 (18.0 %) vs 5 (5.5 + 2.3 %), р &lt; 0.05), family history of cancer (3 (6 %) vs 16 (17.6 %), р &lt; 0.05) and concomitant diseases. Median CA 125 level in group 1 was 64.96 ng/ml and 180 ng/ml in group 2. Ovarian tumors had solid and cystic structure during US examination in 66 (73 %) patients in group 1 and 31 (62 %) patients in group 2 had solid ovarian tumors on US examination.</italic></p><p><bold><italic>Conclusions</italic></bold><bold><italic>. </italic></bold><italic>Th</italic><italic>e differential diagnostics of primary and metastatic ovarian tumors must include CEA, CA 19–9 and CA 125 serum levels and pelvic US.</italic></p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>colon cancer</kwd><kwd>ovarian cancer</kwd><kwd>ovarian metastases</kwd><kwd>synchronous and metachronous tumors</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак толстой кишки</kwd><kwd>рак яичников</kwd><kwd>метастазы в яичники</kwd><kwd>первично-множественные злокачественные новообразования</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Казакевич В.И., Митина Л.А., Востров А.Н., Гуц О.В. Ультразвуковая диагностика метастатического поражения яичников при раке желудочно-кишечного тракта. Ультразвуковая и функциональная диагностика 2009;5:14. [Kazakevitch V.I., Mitina L.A., Vostrov A.N. Guts O.V. Ultrasound diagnosis of metastatic disorder of ovarian in cancer of the gastrointestinal tract. Ultrazvukovaya i funktsionalnaya diagnostika = Ultrasound and functional diagnostics 2009;5:14 (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Казакевич В.И., Митина Л.А., Востров А.Н., Гуц О.В. Ультразвуковая диагностика метастатического поражения яичников при раке желудочно-кишечного тракта. Ультразвуковая и функциональная диагностика 2009;5:14. [Kazakevitch V.I., Mitina L.A., Vostrov A.N. Guts O.V. Ultrasound diagnosis of metastatic disorder of ovarian in cancer of the gastrointestinal tract. Ultrazvukovaya i funktsionalnaya diagnostika = Ultrasound and functional diagnostics 2009;5:14 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Казаков М.П., Поддубная И.В., Любченко Л.Н., Харитонова Т.В. Наследственный рак яичника (литературный обзор). Современная онкология 2012;1(14):47–54. [Kazakov M.P., Poddubnaya I.V., Lubchenco L.N., Kharitonova T.V. Hereditary ovarian cancer (literature review). Sovremennaya onkologiya = Modern oncology 2012;1(14):47–54 (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Казаков М.П., Поддубная И.В., Любченко Л.Н., Харитонова Т.В. Наследственный рак яичника (литературный обзор). Современная онкология 2012;1(14):47–54. [Kazakov M.P., Poddubnaya I.V., Lubchenco L.N., Kharitonova T.V. Hereditary ovarian cancer (literature review). Sovremennaya onkologiya = Modern oncology 2012;1(14):47–54 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Паяниди Ю.Г., Сельчук В.Ю., Жордания К.И. и др. Полинеоплазии жен- ского генитального тракта: первично-мно- жественные новообразования или метастазы? Архив патологии 2006;4:16–20. [Payanidi Y.G., Selchuk V.Y., Jordania K.I. et al. Polyneoplasia of female genital tract: multiple primary tumors or metastases? Arkhiv patologii = Archives of pathology 2006;4: 16–20 (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Паяниди Ю.Г., Сельчук В.Ю., Жордания К.И. и др. Полинеоплазии жен- ского генитального тракта: первично-мно- жественные новообразования или метастазы? Архив патологии 2006;4:16–20. [Payanidi Y.G., Selchuk V.Y., Jordania K.I. et al. Polyneoplasia of female genital tract: multiple primary tumors or metastases? Arkhiv patologii = Archives of pathology 2006;4: 16–20 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Паяниди Ю.Г., Сельчук В.Ю., Жордания К.И. и др. Первично-множественные злокачественные новообразования половых органов у женщин: пути профилактики. Опухоли женской репродуктивной системы 2010;1:51–4. [ Payanidi Y.G., Selchuk V.Y., Jordania K.I. et al. Multiple primary malignant neoplasms of genital organs in women: the way of prevention. Opukholi zhenskoy reproduktivnoy sistemy = Tumors of the female reproductive system 2010;1: 51–4 (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Паяниди Ю.Г., Сельчук В.Ю., Жордания К.И. и др. Первично-множественные злокачественные новообразования половых органов у женщин: пути профилактики. Опухоли женской репродуктивной системы 2010;1:51–4. [ Payanidi Y.G., Selchuk V.Y., Jordania K.I. et al. Multiple primary malignant neoplasms of genital organs in women: the way of prevention. Opukholi zhenskoy reproduktivnoy sistemy = Tumors of the female reproductive system 2010;1: 51–4 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Попова Т.Н. Диагностика и лечебная тактика у больных с первично-множественными синхронными злокачественными опухолями. Дис. … д-ра мед. наук. М., 2002. [Popova T.N. Diagnosis and treatment strategy in patients with multiple primary synchronous malignant tumors. Thesis ... Dr. sci. med. M., 2002 (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Попова Т.Н. Диагностика и лечебная тактика у больных с первично-множественными синхронными злокачественными опухолями. Дис. … д-ра мед. наук. М., 2002. [Popova T.N. Diagnosis and treatment strategy in patients with multiple primary synchronous malignant tumors. Thesis ... Dr. sci. med. M., 2002 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Kim D.D., Park I.J., Kim H.C. et al. Ovarian metastases from colorectal cancer: a clinicopathological analysis of 103 patients. Colorectal Dis 2009 Jan;11(1):32–8.</mixed-citation><mixed-citation xml:lang="ru">Kim D.D., Park I.J., Kim H.C. et al. Ovarian metastases from colorectal cancer: a clinicopathological analysis of 103 patients. Colorectal Dis 2009 Jan;11(1):32–8.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Omranipour R., Abasahl A. Ovarian metastases in colorectal cancer. Int J Gynecol Cancer 2009 Dec;19(9):1524–8.</mixed-citation><mixed-citation xml:lang="ru">Omranipour R., Abasahl A. Ovarian metastases in colorectal cancer. Int J Gynecol Cancer 2009 Dec;19(9):1524–8.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Simon M.S., Petrucelli N. Hereditary breast and ovarian cancer syndrome: the impact of race on uptake of genetic counseling and testing. Methods Mol Biol 2009;471:487–500.</mixed-citation><mixed-citation xml:lang="ru">Simon M.S., Petrucelli N. Hereditary breast and ovarian cancer syndrome: the impact of race on uptake of genetic counseling and testing. Methods Mol Biol 2009;471:487–500.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. La Vecchia C. Epidemiology of ovarian cancer: a summary review. Eur J Cancer Prev 2001;10:125–9.</mixed-citation><mixed-citation xml:lang="ru">La Vecchia C. Epidemiology of ovarian cancer: a summary review. Eur J Cancer Prev 2001;10:125–9.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
